Jefferson University Hospitals

Provider Profile

John L. Wagner, MD

Jefferson University Physician

Academic Title: Professor
Clinical Director, Blood and Marrow Transplant Program

Hematology - Medical Oncology
Medical Oncology
Medical Oncology - Bone Marrow Transplant
Medical Oncology - Hematologic Malignancies
Medical Oncology - Leukemia/Lymphoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

925 Chestnut Street
Suite 420A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340

Medical Services

Years in Practice


Board Certifications

  • Medical Oncology
  • Hematology
  • Internal Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital


Dr. Wagner also specializes in Stem Cell Transplantation and Myeloma/Multiple Myeloma.


  • Temple University School of Medicine, Medical School


  • University of Maryland Medical System


  • University of Maryland Medical System


  • Fred Hutchison Cancer Research Center

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • AmeriHealth
  • Amerihealth Caritas
  • AmeriHealth Comprehensive
  • AmeriHealth HMO
  • AmeriHealth Major Medical
  • AmeriHealth Personal Choice
  • Blue Choice
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Cigna PPO, POS
  • Consumer Health Network PPO
  • CorVel
  • Coventry/Health America
  • Devon
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • Federal BCBS
  • Galaxy
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Inter-County Health Plan
  • Intergroup Preferred
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone First/Connect
  • Keystone Health Plan East
  • Medicaid of New Jersey
  • Medicaid of PA
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • NJ Blue Shield
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • PPO Next
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Qualcare
  • Tricare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease

Investigation of a Clostridium difficile cluster by multilocus sequence typing in a bone marrow transplant unit

Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation

Canine immunogenetics

A2-step approach to myeloablative haploidentical stem cell transplantation: A phase 1/2 trial performed with optimized T-cell dosing

Adenovirus DNA polymerase is recognized by human CD8+T cells

Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy

In vitro methods for generating highly purified EBV associated tumor antigen-specific T cells by using solid phase T cell selection system for immunotherapy

Port site metastasis of B-cell lymphoma: A first occurrence or an underreported complication?

T Cell Repertoire Complexity Is Conserved after LLME Treatment of Donor Lymphocyte Infusions

Sequence of the canine major histocompatibility complex region containing non-classical class I genes

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study

Activity of single-agent melphalan 220-300 mg/m2with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma

Cytoprotection in acute myelogenous leukemia (AML) therapy

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

Molecular Organization of the Canine Major Histocompatibility Complex

Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine major histocompatibility complex